Vicore Pharma Stock Forecast - Polynomial Regression
| VICO Stock | SEK 22.15 0.55 2.42% |
The Polynomial Regression forecasted value of Vicore Pharma Holding on the next trading day is expected to be 22.53 with a mean absolute deviation of 1.06 and the sum of the absolute errors of 64.66. Vicore Stock Forecast is based on your current time horizon.
Vicore |
Most investors in Vicore Pharma cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Vicore Pharma's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Vicore Pharma's price structures and extracts relationships that further increase the generated results' accuracy.
Vicore Pharma polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Vicore Pharma Holding as well as the accuracy indicators are determined from the period prices. Vicore Pharma Polynomial Regression Price Forecast For the 12th of June 2024
Given 90 days horizon, the Polynomial Regression forecasted value of Vicore Pharma Holding on the next trading day is expected to be 22.53 with a mean absolute deviation of 1.06, mean absolute percentage error of 1.59, and the sum of the absolute errors of 64.66.Please note that although there have been many attempts to predict Vicore Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Vicore Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Vicore Pharma Stock Forecast Pattern
| Backtest Vicore Pharma | Vicore Pharma Price Prediction | Buy or Sell Advice |
Vicore Pharma Forecasted Value
In the context of forecasting Vicore Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Vicore Pharma's downside and upside margins for the forecasting period are 18.46 and 26.61, respectively. We have considered Vicore Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Vicore Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Vicore Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.5722 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.06 |
| MAPE | Mean absolute percentage error | 0.0587 |
| SAE | Sum of the absolute errors | 64.6628 |
Predictive Modules for Vicore Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vicore Pharma Holding. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vicore Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Vicore Pharma
For every potential investor in Vicore, whether a beginner or expert, Vicore Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vicore Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vicore. Basic forecasting techniques help filter out the noise by identifying Vicore Pharma's price trends.Vicore Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vicore Pharma stock to make a market-neutral strategy. Peer analysis of Vicore Pharma could also be used in its relative valuation, which is a method of valuing Vicore Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Vicore Pharma Holding Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Vicore Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Vicore Pharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Vicore Pharma Market Strength Events
Market strength indicators help investors to evaluate how Vicore Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vicore Pharma shares will generate the highest return on investment. By undertsting and applying Vicore Pharma stock market strength indicators, traders can identify Vicore Pharma Holding entry and exit signals to maximize returns.
| Accumulation Distribution | 7436.77 | |||
| Daily Balance Of Power | (0.55) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 22.4 | |||
| Day Typical Price | 22.32 | |||
| Price Action Indicator | (0.53) | |||
| Period Momentum Indicator | (0.55) |
Vicore Pharma Risk Indicators
The analysis of Vicore Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vicore Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vicore stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.83 | |||
| Semi Deviation | 2.24 | |||
| Standard Deviation | 3.95 | |||
| Variance | 15.63 | |||
| Downside Variance | 7.61 | |||
| Semi Variance | 5.02 | |||
| Expected Short fall | (3.55) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Vicore Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vicore Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Vicore Stock
Moving against Vicore Stock
| 0.82 | NANOFS | Nanoform Finland Plc | PairCorr |
| 0.71 | ONCO | Oncopeptides AB | PairCorr |
| 0.66 | SCOL | Scandion Oncology | PairCorr |
The ability to find closely correlated positions to Vicore Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vicore Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vicore Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vicore Pharma Holding to buy it.
The correlation of Vicore Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vicore Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vicore Pharma Holding moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vicore Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.